-+ 0.00%
-+ 0.00%
-+ 0.00%

Galmed Pharmaceuticals Announces Phase 1/2 Study of Aramchol and Regorafenib in Liver Cancer

Reuters·12/08/2025 13:30:41

Please log in to view news